Results 181 to 190 of about 33,865 (284)

Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy‐induced nausea and vomiting [PDF]

open access: bronze, 2003
S. Poli-Bigelli   +8 more
openalex   +1 more source

Evaluation of Antiemetic Consistency in Chemotherapy-Induced Nausea and Vomiting Among NHL Patients in Sana’a, Yemen

open access: yesInternational Journal of General Medicine
Mohammed Mohammed Battah,1,2 Hadzliana Zainal,1 Doa’a Anwar Ibrahim,2 Nur Hafzan Binti Md Hanafiah,1 Syed Azhar Syed Sulaiman,1 Abdulsalam Halboup1,2 1Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang ...
Battah MM   +5 more
doaj  

Practical Management of Zolbetuximab Administration: The Project VYLOY Initiative. [PDF]

open access: yesCancers (Basel)
Narita Y   +14 more
europepmc   +1 more source

Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5‐hydroxytryptamine‐3 antiemetics [PDF]

open access: bronze, 2003
Jane T. Hickok   +5 more
openalex   +1 more source

Antiemetic Prophylaxis for Office-based Surgery [PDF]

open access: bronze, 2003
Jun Tang   +9 more
openalex   +1 more source

Evaluation of chemotherapy-induced nausea and vomiting in low, moderate, and highly emetogenic schemes between sexes. [PDF]

open access: yesSupport Care Cancer
Albanell-Fernández M   +8 more
europepmc   +1 more source

Guideline for the Treatment of Breakthrough and the Prevention of Refractory Chemotherapy-induced Nausea and Vomiting in Children with Cancer [PDF]

open access: yes, 2016
Basch   +31 more
core   +1 more source

Home - About - Disclaimer - Privacy